Bank of Montreal Can Has $4.99 Million Holdings in Balchem Co. (NASDAQ:BCPC)

Bank of Montreal Can increased its holdings in Balchem Co. (NASDAQ:BCPC) by 1.6% during the third quarter, HoldingsChannel reports. The fund owned 28,488 shares of the basic materials company’s stock after acquiring an additional 456 shares during the quarter. Bank of Montreal Can’s holdings in Balchem were worth $4,989,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Balchem by 1.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock worth $604,000 after acquiring an additional 59 shares during the last quarter. Inspire Investing LLC grew its position in Balchem by 2.7% in the 3rd quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after purchasing an additional 62 shares in the last quarter. Hsbc Holdings PLC grew its position in Balchem by 1.5% in the 2nd quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock worth $757,000 after purchasing an additional 75 shares in the last quarter. Atomi Financial Group Inc. grew its position in Balchem by 6.1% in the 3rd quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock worth $295,000 after purchasing an additional 96 shares in the last quarter. Finally, Xponance Inc. grew its position in Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock worth $315,000 after purchasing an additional 102 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Analyst Upgrades and Downgrades

BCPC has been the subject of a number of research reports. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th. HC Wainwright increased their target price on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th.

Balchem Stock Down 1.7 %

BCPC opened at $177.99 on Wednesday. The company has a 50 day moving average of $174.61 and a 200 day moving average of $167.93. The company has a market cap of $5.79 billion, a PE ratio of 47.85, a price-to-earnings-growth ratio of 5.41 and a beta of 0.67. Balchem Co. has a 12 month low of $124.34 and a 12 month high of $186.03. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.